| Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets V Miranda-Goncalves, M Honavar, C Pinheiro, O Martinho, MM Pires, ... Neuro-oncology 15 (2), 172-188, 2013 | 293 | 2013 |
| Zeolite structures loading with an anticancer compound as drug delivery systems R Amorim, N Vilaça, O Martinho, RM Reis, M Sardo, J Rocha, ... The Journal of Physical Chemistry C 116 (48), 25642-25650, 2012 | 157 | 2012 |
| Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas O Martinho, A Longatto-Filho, MBK Lambros, A Martins, C Pinheiro, ... British journal of cancer 101 (6), 973-982, 2009 | 146 | 2009 |
| Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas V Miranda-Gonçalves, S Granja, O Martinho, M Honavar, M Pojo, ... Oncotarget 7 (29), 46335, 2016 | 111 | 2016 |
| Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study BM Costa, C Caeiro, I Guimarães, O Martinho, T Jaraquemada, I Augusto, ... Oncology reports 23 (6), 1655-1662, 2010 | 80 | 2010 |
| Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs) ATT De Oliveira, C Pinheiro, A Longatto-Filho, MJ Brito, O Martinho, ... Journal of bioenergetics and biomembranes 44, 171-178, 2012 | 77 | 2012 |
| Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma A Longatto-Filho, C Pinheiro, O Martinho, MAR Moreira, LFJ Ribeiro, ... BMC cancer 9, 1-8, 2009 | 77 | 2009 |
| Loss of RKIP expression is associated with poor survival in GISTs O Martinho, A Gouveia, P Silva, A Pimenta, RM Reis, JM Lopes Virchows Archiv 455, 277-284, 2009 | 77 | 2009 |
| In vitro and in vivo analysis of RTK inhibitor efficacy and identification of its novel targets in glioblastomas O Martinho, R Silva-Oliveira, V Miranda-Goncalves, C Clara, JR Almeida, ... Translational oncology 6 (2), 187-IN20, 2013 | 70 | 2013 |
| Glucose addiction in cancer therapy: advances and drawbacks S Granja, C Pinheiro, R Manuel Reis, O Martinho, F Baltazar Current drug metabolism 16 (3), 221-242, 2015 | 69 | 2015 |
| Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas O Martinho, S Granja, T Jaraquemada, C Caeiro, V Miranda-Gonçalves, ... PloS one 7 (1), e30769, 2012 | 69 | 2012 |
| RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy O Martinho, F Pinto, S Granja, V Miranda-Gonçalves, MAR Moreira, ... PloS one 8 (3), e59104, 2013 | 68 | 2013 |
| Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas V de Lima Vazquez, AL Vicente, A Carloni, G Berardinelli, P Soares, ... Melanoma research 26 (2), 93-99, 2016 | 60 | 2016 |
| Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness S Moniz, O Martinho, F Pinto, B Sousa, C Loureiro, MJ Oliveira, LF Moita, ... Human molecular genetics 22 (1), 84-95, 2013 | 57 | 2013 |
| Encapsulation of α-cyano-4-hydroxycinnamic acid into a NaY zeolite N Vilaça, R Amorim, O Martinho, RM Reis, F Baltazar, AM Fonseca, ... Journal of materials science 46, 7511-7516, 2011 | 52 | 2011 |
| Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild‐type GISTs O Martinho, A Gouveia, M Viana‐Pereira, P Silva, A Pimenta, RM Reis, ... Histopathology 55 (1), 53-62, 2009 | 46 | 2009 |
| Molecular alterations of KIT oncogene in gliomas AL Gomes, JS Reis-Filho, JM Lopes, O Martinho, MBK Lambros, ... Analytical Cellular Pathology 29 (5), 399-408, 2007 | 46 | 2007 |
| Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells VAO Silva, MN Rosa, V Miranda-Gonçalves, AM Costa, A Tansini, ... Investigational New Drugs 37, 223-237, 2019 | 44 | 2019 |
| Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker RJ Silva-Oliveira, VAO Silva, O Martinho, A Cruvinel-Carloni, ... Cellular Oncology 39, 253-263, 2016 | 43 | 2016 |
| In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer‑derived cell lines VAO Silva, MN Rosa, A Tansini, RJS Oliveira, O Martinho, JP Lima, ... Experimental and Therapeutic Medicine 16 (2), 557-566, 2018 | 42 | 2018 |
Rui Manuel ReisBarretos Cancer Hospital (Brazil) and Minho University (Portugal)Verified email at hcancerbarretos.com.br
